MHC class II presentation of endogenously expressed antigens by transfected dendritic cells

被引:102
作者
Diebold, SS
Cotten, M
Koch, N
Zenke, M
机构
[1] Max Delbruck Ctr Mol Med, MDC, D-13092 Berlin, Germany
[2] Inst Mol Pathol, IMP, A-1030 Vienna, Austria
[3] Univ Bonn, Inst Zool, Dept Immunobiol, D-5300 Bonn, Germany
关键词
dendritic cells; MHC class II; invariant chain; ovalbumin; Ad/PEI transfection;
D O I
10.1038/sj.gt.3301433
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dendritic cells (DC) present immunogenic epitopes of antigens in the context of MHC class I and class II molecules in association with costimulatory molecules, and efficiently activate both cytotoxic T cells and T helper cells. Gene modified DC expressing antigen encoding cDNA represent a particularly attractive approach for the immunotherapy of disease. We previously described a gene delivery system for DC based on receptor-mediated endocytosis of ligand/polyethylenimine (PEI) DNA transfer complexes that target cell surface receptors which are abundantly expressed on DC. Employing this gene delivery system, DC were generated that express chicken ovalbumin (OVA) cDNA as a model antigen and introduce antigen into the MHC class I presentation pathway. We demonstrate here that modification of OVA cDNA as transferrin receptor (TfR) or invariant chain (li) fusions effectively generate MHC class II specific immune responses in addition to MHC class I responses. TfR-OVA contains the membrane anchoring region of transferrin receptor and represents a membrane-bound form of OVA for access to the MHC class II compartment. li-OVA fusions directly target the MHC class II processing pathway. Thus, modification of antigen encoding cDNA represents a convenient and effective means to direct antigens to MHC class II presentation and thus to generate T cell help.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 49 条
[1]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[2]  
Austyn J M, 1998, Curr Opin Hematol, V5, P3, DOI 10.1097/00062752-199801000-00002
[3]   Delivery of bacterial artificial chromosomes into mammalian cells with psoralen-inactivated adenovirus carrier [J].
Baker, A ;
Cotten, M .
NUCLEIC ACIDS RESEARCH, 1997, 25 (10) :1950-1956
[4]   Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery [J].
Baker, A ;
Saltik, M ;
Lehrmann, H ;
Killisch, I ;
Mautner, V ;
Lamm, G ;
Christofori, G ;
Cotten, M .
GENE THERAPY, 1997, 4 (08) :773-782
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   DETECTION OF FUNCTIONAL CLASS II-ASSOCIATED ANTIGEN - ROLE OF A LOW-DENSITY ENDOSOMAL COMPARTMENT IN ANTIGEN-PROCESSING [J].
BARNES, KA ;
MITCHELL, RN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1715-1727
[7]   Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor [J].
Baxevanis, CN ;
Voutsas, IF ;
Tsitsilonis, OE ;
Gritzapis, AD ;
Sotiriadou, R ;
Papamichail, M .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3902-3912
[8]   Cancer immunotherapy: synthetic and natural peptides in the balance [J].
Bellone, M ;
Iezzi, G ;
Imro, MA ;
Protti, MP .
IMMUNOLOGY TODAY, 1999, 20 (10) :457-462
[9]   Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo [J].
Boczkowski, D ;
Nair, SK ;
Snyder, D ;
Gilboa, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :465-472
[10]   Tumor antigens recognized by T cells [J].
Boon, T ;
Coulie, PG ;
VandenEynde, B .
IMMUNOLOGY TODAY, 1997, 18 (06) :267-268